SAMSCA Treatment for Dilutional Hyponatremia
SAMSCA is indicated for the treatment of clinically significant hypervolemic and euvolemic hyponatremia. Learn about the risk factors for hyponatremia, an electrolyte disorder that can affect a variety of patient types in the hospital.